Zacks Research Predicts Cardinal Health FY2025 Earnings

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Equities researchers at Zacks Research boosted their FY2025 earnings per share estimates for Cardinal Health in a research note issued on Thursday, May 22nd. Zacks Research analyst R. Department now forecasts that the company will post earnings of $8.09 per share for the year, up from their prior forecast of $7.88. The consensus estimate for Cardinal Health's current full-year earnings is $7.95 per share. Zacks Research also issued estimates for Cardinal Health's Q4 2025 earnings at $1.93 EPS, Q1 2026 earnings at $2.08 EPS, Q2 2026 earnings at $1.99 EPS, Q4 2026 earnings at $2.38 EPS, FY2026 earnings at $8.98 EPS, Q1 2027 earnings at $2.20 EPS, Q2 2027 earnings at $2.23 EPS, Q3 2027 earnings at $2.62 EPS and FY2027 earnings at $9.77 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the previous year, the business earned $2.08 earnings per share. The firm's revenue was up .0% compared to the same quarter last year.

Several other research analysts have also weighed in on the company. Citigroup reissued a "neutral" rating on shares of Cardinal Health in a research report on Thursday, May 1st. Wells Fargo & Company upped their target price on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Argus set a $148.00 price objective on shares of Cardinal Health in a research note on Tuesday, February 4th. UBS Group upped their price target on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Finally, Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Four equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $146.43.

Cardinal Health Trading Up 1.2%

NYSE:CAH traded up $1.90 during trading hours on Monday, hitting $154.65. 1,901,089 shares of the stock traded hands, compared to its average volume of 2,230,522. The firm has a 50 day moving average price of $140.43 and a 200 day moving average price of $129.66. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $156.44. The firm has a market cap of $36.91 billion, a price-to-earnings ratio of 28.85, a PEG ratio of 1.49 and a beta of 0.66.

Institutional Investors Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Pinnacle Bancorp Inc. grew its position in Cardinal Health by 11.2% in the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock worth $106,000 after purchasing an additional 77 shares during the last quarter. Rothschild Investment LLC grew its holdings in shares of Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after purchasing an additional 79 shares in the last quarter. Applied Finance Capital Management LLC grew its holdings in shares of Cardinal Health by 1.4% during the 1st quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock worth $833,000 after purchasing an additional 85 shares in the last quarter. CSS LLC IL grew its holdings in shares of Cardinal Health by 0.8% during the 4th quarter. CSS LLC IL now owns 11,190 shares of the company's stock worth $1,323,000 after purchasing an additional 90 shares in the last quarter. Finally, Perigon Wealth Management LLC grew its holdings in shares of Cardinal Health by 4.2% during the 1st quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock worth $309,000 after purchasing an additional 90 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.32%. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.